The Relationship Between Belief, Expectation, and Adherence to Therapy During COVID-19 Pandemic
NCT ID: NCT06530472
Last Updated: 2024-07-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
196 participants
OBSERVATIONAL
2021-05-18
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* \[question
* \[question Participants will \[describe the main tasks participants will be asked to do, treatments they'll be given and use bullets if it is more than 2 items \].
If there is a comparison group: Researchers will compare insert groups \] to see if insert effects
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fondazione Don Carlo Gnocchi
All patients diagnosed with ischaemic heart disease established by angiography; attained age of majority; Score \>= 26 on the Montreal Cognitive Assessment (MoCA) test. At baseline, 3, 6 and 12 months, people will undergo to both a psychological and cardiological assessment.
Monitoring
At baseline, 3, 6 and 12 months, people will undergo to both a psychological and cardiological assessment.
Ospedale Valduce
All patients diagnosed with ischaemic heart disease established by angiography; attained age of majority; Score \>= 26 on the Montreal Cognitive Assessment (MoCA) test. At baseline, 3, 6 and 12 months, people will undergo to both a psychological and cardiological assessment.
Monitoring
At baseline, 3, 6 and 12 months, people will undergo to both a psychological and cardiological assessment.
Ospedale Cà Granda Niguarda
All patients diagnosed with ischaemic heart disease established by angiography; attained age of majority; Score \>= 26 on the Montreal Cognitive Assessment (MoCA) test. At baseline, 3, 6 and 12 months, people will undergo to both a psychological and cardiological assessment.
Monitoring
At baseline, 3, 6 and 12 months, people will undergo to both a psychological and cardiological assessment.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Monitoring
At baseline, 3, 6 and 12 months, people will undergo to both a psychological and cardiological assessment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* reaching the age of majority;
* score \>= 26 on the Montreal Cognitive Assessment (MoCA) test (Nasreddine et al., 2005).
Exclusion Criteria
* pregnancy;
* participants with neurological pathologies that significantly impair their cognitive functions (e.g. advanced Parkinson's disease; Alzheimer's dementia...cardiac arrest with hypoxic damage);
* participants with cognitive impairments that compromise comprehension and sharing of the contents of the questions, detected through the administration of the Montreal Cognitive Assessment (MoCA) test (Nasreddine et al., 2005).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ospedale Valduce, Como
UNKNOWN
Azienda Ospedaliera Niguarda Cà Granda
OTHER
Fondazione Don Carlo Gnocchi Onlus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IRCCS Fondazione Don Carlo Gnocchi
Milan, MI, Italy
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Broadbent E, Petrie KJ, Main J, Weinman J. The brief illness perception questionnaire. J Psychosom Res. 2006 Jun;60(6):631-7. doi: 10.1016/j.jpsychores.2005.10.020.
Evers AW, Kraaimaat FW, van Lankveld W, Jongen PJ, Jacobs JW, Bijlsma JW. Beyond unfavorable thinking: the illness cognition questionnaire for chronic diseases. J Consult Clin Psychol. 2001 Dec;69(6):1026-36.
Miyazaki M, Nakashima A, Nakamura Y, Sakamoto Y, Matsuo K, Goto M, Uchiyama M, Okamura K, Mitsutake R, Urata H, Kamimura H, Imakyure O. Association between medication adherence and illness perceptions in atrial fibrillation patients treated with direct oral anticoagulants: An observational cross-sectional pilot study. PLoS One. 2018 Sep 28;13(9):e0204814. doi: 10.1371/journal.pone.0204814. eCollection 2018.
Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005 Aug 4;353(5):487-97. doi: 10.1056/NEJMra050100. No abstract available.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FDG_88-15
Identifier Type: -
Identifier Source: org_study_id